Session 21The Future of Phase I Trials: New Approaches and Innovations
Session 22Biostatistics in Clinical Research: Challenges and Innovations
Session 23Clinical Trials in Rare Diseases: Overcoming Challenges
Session 24Mobile Health Applications in Clinical Trials: Revolutionizing Data Collection
Session 25Ethics of Placebo-Controlled Trials: Addressing Concerns and Dilemmas
Session 26Improving Diversity and Inclusion in Clinical Trials
Session 27Innovative Technologies in Drug Development and Clinical Testing
Session 28The Role of Clinical Research Organizations (CROs) in Clinical Trials
Session 29Clinical Trial Transparency: Addressing Public Trust and Reporting
Session 30Future Directions in Clinical Research: Trends, Challenges, and Innovations